Latest papers

[Peculiarities of neuroleptic syndrome in women treated with typical and atypical neuroleptics]

Zuclopenthixol-induced neuroleptic malignant syndrome presenting as fever of unknown origin, hyperglycaemia and acute myocardial infarction in a 60-year-old man.

Atypical neuroleptic malignant syndrome or serotonin toxicity associated with atypical antipsychotics?

Neuroleptic malignant syndrome associated with atypical antipsychotic drugs.

Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.

[Increase of serum procalcitonin levels during a neuroleptic malignant syndrome].

Neuropsychiatric systemic lupus erythematosus associated with neuroleptic malignant syndrome.

Tardive seizure and antibiotics: case reports and review of the literature.

Extreme creatine phosphokinase elevation in a 20-year-old man participating in a clinical trial of major depressive disorder.

Neuroleptic rechallenge with aripiprazole in a patient with previously documented neuroleptic malignant syndrome.

Psychosis or atypical neuroleptic malignant syndrome in an adolescent?

Intrathecal baclofen withdrawal resembling serotonin syndrome in an adolescent boy with cerebral palsy.

Association between selective serotonin-reuptake inhibitors, second-generation antipsychotics, and neuroleptic malignant syndrome.

Probable case of neuroleptic malignant syndrome following administration of antituberculotic drugs in a chlorpromazine-treated patient.

Neuroleptic malignant syndrome and the acute phase response.

Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.

A Case of neuroleptic malignant syndrome accompanied to an atypical antipsychotic agent: risperidone.

Neuroleptic malignant syndrome.

[Anesthetic management for electroconvulsive therapy using target-controlled infusion of propofol].

Neuroleptic malignant syndrome and catatonia in a patient with dementia.